Deutivacaftor + Tezacaftor + Vanzacaftor 10 mg + 50 mg + 125mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg + 50 mg + 125mg
Reference Brands: Alyftrek (USA)
Category: Orphan Drugs
Deutivacaftor + Tezacaftor + Vanzacaftor is a Orphan Drugs product available as Tablets in strengths 10 mg + 50 mg + 125mg. It corresponds to the reference brand Alyftrek (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Alyftrek is a fixed-dose combination oral medication containing vanzacaftor, tezacaftor, and deutivacaftor, developed for the treatment of cystic fibrosis (CF). The drug is specifically indicated for patients aged six years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor, formulated as vanzacaftor calcium dihydrate, and tezacaftor help improve the processing and trafficking of the defective CFTR protein to the cell surface, while deutivacaftor enhances its function by increasing channel opening probability.
By acting on the underlying genetic defect, Alyftrek improves chloride transport across epithelial cell membranes, helping to hydrate mucus in the lungs and digestive tract. This leads to improved lung function, reduced pulmonary exacerbations, and better overall symptom management in eligible patients. Administered orally once daily, the medication offers a convenient and effective treatment option for cystic fibrosis, supporting long-term disease management and enhancing quality of life. Alyftrek represents a next-generation therapy for CF, providing targeted correction of CFTR protein function in patients with responsive mutations.
Deutivacaftor + Tezacaftor + Vanzacaftor — third party manufacturing & bulk supply
Deutivacaftor + Tezacaftor + Vanzacaftor 10 mg + 50 mg + 125mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Deutivacaftor + Tezacaftor + Vanzacaftor listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Deutivacaftor + Tezacaftor + Vanzacaftor →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Alyftrek is used for the treatment of cystic fibrosis in patients aged 6 years and older who have at least one responsive CFTR gene mutation, including the F508del mutation. It helps improve lung function, reduce pulmonary exacerbations, and manage symptoms associated with cystic fibrosis.
Alyftrek contains a combination of three CFTR modulator components: deutivacaftor, tezacaftor, and vanzacaftor. These work together to increase the quantity and function of the CFTR protein at the cell surface.
The trade name of this combination therapy is Alyftrek.
Alyftrek is manufactured and marketed by Vertex Pharmaceuticals Incorporated.
The generic names are deutivacaftor, tezacaftor, and vanzacaftor.
The brand name is Alyftrek.
Alyftrek is manufactured in FDA-, EMA-, and MHRA-approved facilities by Vertex Pharmaceuticals for distribution in the USA, EU, and UK.
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
